Food Is Medicine: 7 Liver-Protecting Habits from a Mumbai Hepatologist
By Dr. Chetan Kalal — DM (Hepatology) · MD (Medicine) · MRCP (UK) First DM Hepatologist of Maharashtra · Associate Director, Hepatology & Transplant Medicine, Gleneagles Mumbai
What a hepatologist actually eats for
I do not use the phrase "food is medicine" loosely. I use it because the liver is the organ most directly exposed to everything you absorb from your gut — the hepatic portal vein delivers the chemical consequence of every meal directly to your hepatocytes before any other organ sees it. What you eat is not a lifestyle variable at the margins of liver health. It is a primary determinant.
These are not general wellness tips. Each habit maps to a specific mechanism of hepatic injury or protection — and I have structured them that way deliberately, because patients who understand why something matters are far more likely to sustain it.
Habit 1: Eliminate fructose, not fat
The most dangerous substance in the modern Indian diet for liver health is not cooking oil. It is fructose — specifically in the form of sugar-sweetened beverages (packaged fruit juice, soft drinks, energy drinks, packaged nimbu pani) and high-fructose corn syrup used in ultraprocessed snacks.
Unlike glucose, fructose is almost exclusively metabolised in the liver. At high loads, it overwhelms the liver's capacity for normal metabolism and is shunted into de novo lipogenesis — the synthesis of new fat — within hepatocytes. This is the primary dietary driver of non-alcoholic fatty liver disease (NAFLD/MAFLD) independent of total caloric intake.
The evidence here is robust. Stanhope et al. (2009, J Clin Invest, PMID 19381015) demonstrated that isocaloric fructose consumption produced significantly greater hepatic fat accumulation than glucose in controlled conditions. The mechanism is not caloric — it is biochemical.
Indian context: A 300ml tetra-pack of a branded "fruit drink" contains 25–35g of sugar, predominantly fructose or sucrose (50% fructose by composition). This is not fruit. It is a fructose delivery vehicle. Replace it with water, unsweetened chaas (buttermilk), or plain nimbu pani with minimal sugar.
Habit 2: Drink coffee — and do not feel guilty about it
This is the most evidence-backed dietary hepatoprotective intervention in the literature, and it remains underappreciated in Indian clinical practice because of cultural ambivalence about coffee.
Regular coffee consumption — two or more cups per day — is associated with reduced risk of liver fibrosis progression, lower incidence of cirrhosis, and a significant reduction in hepatocellular carcinoma (HCC) risk. The meta-analysis by Kennedy et al. (Aliment Pharmacol Ther, 2016, PMID 27194895) showed that two additional cups of coffee per day were associated with a 44% lower risk of liver cirrhosis. A separate analysis demonstrated reduced all-cause liver-related mortality in NAFLD patients who consumed coffee regularly.
The mechanism is multifactorial: coffee's diterpenes and chlorogenic acids modulate TGF-β1 signalling (a key driver of hepatic stellate cell activation and fibrosis), reduce oxidative stress in hepatocytes, and appear to lower hepatic fat content independently of caffeine.
Critical caveat: This applies to black or minimally sweetened filter coffee or espresso. Three spoons of sugar and full-fat cream in a café-style beverage partially negates the benefit. South Indian filter coffee with modest sugar is acceptable. A 500ml sweetened cold coffee from a café is not this habit.
Chai has not demonstrated the same hepatoprotective signal in the literature as coffee. I cannot make an equivalent claim for tea.
Habit 3: Build your meals around the Indian Mediterranean pattern
The Mediterranean diet has the strongest dietary evidence base for NAFLD reduction — demonstrated in multiple RCTs and cohort studies including the PREDIMED trial (Estruch et al., NEJM, 2013, PMID 23432189), which showed cardiovascular and metabolic benefit that extends to liver outcomes via shared pathways of insulin resistance and inflammation.
The practical challenge is cultural translation. Indian patients do not eat olive oil and grilled fish. But the structural principles are entirely achievable in Indian cuisine:
The hepatoprotective dietary architecture emphasises abundant vegetables and legumes (dal, rajma, chana — excellent sources of plant protein and soluble fibre that feed the gut microbiome and reduce portal endotoxin load), minimally processed whole grains (replacing maida with jowar, bajra, or whole wheat), liberal use of nuts and seeds (walnuts and flaxseed contain ALA, a plant omega-3 with anti-inflammatory properties), fatty fish when culturally acceptable (mackerel and sardines are accessible and contain EPA/DHA at meaningful levels), and olive oil or mustard oil as primary cooking fats over refined vegetable oils high in omega-6 PUFA.
The mechanism is convergent: this dietary pattern reduces hepatic NF-κB activation (the master inflammatory transcription factor), decreases circulating free fatty acid flux to the liver, improves insulin sensitivity, and reduces gut permeability — all of which directly attenuate NAFLD progression.
What to reduce, specifically: Maida-based products (white bread, biscuits, pav, refined namkeen), packaged ready-to-eat snacks, and anything fried in repeatedly heated oil — which generates aldehyde oxidation products with documented hepatotoxic potential.
Habit 4: Resistance training is a liver intervention
Exercise is not in scope for a dietary habits piece — except that skeletal muscle is a primary site of hepatic insulin resistance, and building muscle mass directly reduces the metabolic burden on the liver. I include it because the mechanism is inseparable from dietary management and the evidence warrants it.
In lean NAFLD patients particularly (see my prior piece on this), resistance training — not aerobic exercise alone — is the most effective lifestyle intervention for reducing hepatic steatosis and improving liver enzymes. The mechanism involves GLUT4 upregulation in myocytes, improved glucose disposal in skeletal muscle, and reduction of intramyocellular lipid deposits that contribute to systemic insulin resistance.
A 2017 systematic review in the Journal of Hepatology (Hashida et al., PMID 28126330) demonstrated that both aerobic and resistance exercise reduced hepatic fat content, with resistance training showing greater benefit on metabolic parameters. Verify this citation independently before publication.
For Indian patients: 2–3 sessions per week of progressive resistance training (bodyweight, gym, or resistance bands) is the minimum meaningful dose. Combined with the dietary changes above, the synergistic effect on liver outcomes is substantive.
Habit 5: Stop the supplement stack
This is the habit that generates the most resistance from patients — and it is the one I am most insistent about.
Drug-induced liver injury (DILI) from over-the-counter supplements — including protein powders, herbal formulations, ayurvedic preparations, and fat-burning supplements — is the fastest-growing category of hepatotoxicity presenting to liver clinics in India. It is also the most underdiagnosed, because patients do not consider supplements as "drugs" and physicians do not systematically ask about them.
The hepatotoxic culprits commonly encountered in Indian clinical practice include high-dose whey protein powders adulterated with hepatotoxic compounds, ayurvedic preparations containing undisclosed heavy metals (arsenic, lead, mercury), green tea extract at supplement doses (EGCG is dose-dependently hepatotoxic — the evidence is unambiguous), and multi-ingredient sports supplements combining stimulants with herbal extracts.
The principle is simple: if a substance is metabolised by the liver — and almost everything taken orally is — it has hepatotoxic potential at sufficient dose or in the presence of pre-existing liver disease. A liver that is already dealing with steatosis or early fibrosis is less equipped to handle additional metabolic load from unnecessary supplementation.
If you have a liver condition, every supplement you take — including "natural" preparations — should be discussed with your hepatologist before continuation.
Habit 6: Feed your gut microbiome deliberately
The gut-liver axis is one of the most significant concepts in modern hepatology. The liver receives 70% of its blood supply from the portal vein, which drains the intestinal tract — meaning that the products of gut bacterial metabolism reach the liver first, at high concentration, before being diluted into systemic circulation.
In a disrupted gut microbiome (dysbiosis), increased gut permeability allows bacterial endotoxins — specifically lipopolysaccharide (LPS) from gram-negative bacteria — to translocate into portal blood and reach the liver. LPS activates Toll-like receptor 4 (TLR4) on Kupffer cells, triggering an inflammatory cascade that accelerates NAFLD progression and fibrosis.
The dietary approach to gut microbiome support is not complicated: fibre diversity drives bacterial diversity. Each distinct plant food feeds a different bacterial community. The widely cited "30 plants per week" framework from the American Gut Project data is a practical heuristic — it is the diversity of plant food, not the volume, that correlates with microbiome richness.
Indian dietary advantage: The traditional Indian vegetarian diet is structurally excellent for microbiome health — multiple dals, sabzis, and fermented foods (curd, idli, dosa, kanji) in a single day easily achieve meaningful fibre and probiotic diversity. The degradation of this pattern by ultraprocessed convenience foods is a direct threat to gut-liver axis health.
Specific additions worth considering: psyllium husk (isabgol) — 5g daily in water is one of the most evidence-backed soluble fibre interventions for gut health and metabolic benefit in Indian patients. Fermented foods daily — curd (full-fat, plain, without added sugar) at a minimum.
Habit 7: Reframe your relationship with alcohol — completely
No article on liver protection is complete without stating what the evidence demands be stated plainly: there is no established safe lower threshold of alcohol consumption for individuals with pre-existing liver disease.
The concept of "moderate drinking" being liver-safe is valid only in the context of a histologically normal liver. In the presence of steatosis (including NAFLD), hepatitis B or C, autoimmune liver disease, or genetic metabolic liver conditions, even low-volume alcohol consumption produces additive hepatotoxic effects.
The mechanism is additive oxidative stress — both NAFLD and alcohol independently generate reactive oxygen species in hepatocytes through cytochrome P450 2E1 (CYP2E1) activation, mitochondrial dysfunction, and lipid peroxidation. In combination, the hepatotoxic insult is synergistic.
The clinical implication for Indian patients is specific: a very substantial proportion of people presenting to hepatology clinics with "NAFLD" in Indian cities have a dual aetiology — metabolic steatosis plus regular alcohol use that falls below what they would classify as "heavy drinking." Two drinks on weekends. Beer after cricket. Wine at social events. In the context of pre-existing metabolic liver disease, this is not harmless social consumption. It is an accelerant.
The honest advice: If you have a fatty liver, elevated liver enzymes, or any diagnosed liver condition — the answer is zero alcohol. Not moderation. Not "cutting back." Zero.
What these seven habits share
None of them require expensive interventions, imported foods, or pharmaceutical supplements. They require understanding the mechanism and applying it consistently within the food culture that already exists in Indian households.
The liver is a remarkably forgiving organ in early disease — with the right dietary environment, it can reduce steatosis, dampen inflammation, and slow or reverse fibrosis in stages F0–F2. It does not forgive indefinite neglect.
If your liver enzymes are elevated, you have been diagnosed with fatty liver, or you want a structured hepatology review of your metabolic risk — book a consultation.
In-person in Mumbai or virtual consult internationally: drchetankalal.com
Clinical accuracy note: Nutritional hepatology evidence ranges from robust RCT-level data (coffee, fructose restriction, exercise) to promising but preliminary data (specific polyphenols, turmeric/curcumin at dietary doses). Curcumin at dietary doses has not demonstrated the same effect size as pharmacological curcumin extracts — I have excluded it from this piece deliberately. Patients should not interpret this article as individualised medical advice.
